Cargando…

Quantitative plasma proteome profiling of COVID-19 patients with mild and moderate symptoms

Detalles Bibliográficos
Autores principales:	Jiang, He-wei, Tao, Sheng-ce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702381/ https://www.ncbi.nlm.nih.gov/pubmed/34959132 http://dx.doi.org/10.1016/j.ebiom.2021.103773

Ejemplares similares

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
por: Zhong, Wen, et al.
Publicado: (2021)

SARS-CoV-2 peptides/epitopes for specific and sensitive diagnosis
por: Jiang, He-Wei, et al.
Publicado: (2023)

PIONEER trial: favipiravir to treat moderate COVID-19
por: Shalhoub, Sarah
Publicado: (2023)

Azithromycin: can its benefit be ruled out in mild COVID-19?
por: Rodríguez-Molinero, Alejandro
Publicado: (2021)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Convalescent plasma in patients hospitalised with COVID-19
por: Liu, Sean T H, et al.
Publicado: (2021)

SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling
por: Lai, Dan-yun, et al.
Publicado: (2022)

Convalescent plasma as a potential therapy for COVID-19
por: Chen, Long, et al.
Publicado: (2020)

Self-perception of acute symptoms in adolescents with COVID-19
por: Gnecchi, Massimiliano
Publicado: (2022)

Convalescent plasma from people vaccinated after COVID-19 infection
por: Jabal, Kamal Abu, et al.
Publicado: (2021)

Comment on Rauchman et al. Mild-to-Moderate Traumatic Brain Injury: A Review with Focus on the Visual System. Neurol. Int. 2022, 14, 453–470
por: Erdinest, Nir, et al.
Publicado: (2022)

Clinical Symptom Profiles After Mild–Moderate Stroke
por: Katzan, Irene L., et al.
Publicado: (2019)

Symptom study app provides real-world data on COVID-19 vaccines
por: Drury, Ruth E, et al.
Publicado: (2021)

Comment on Grivas et al. Morphology, Development and Deformation of the Spine in Mild and Moderate Scoliosis: Are Changes in the Spine Primary or Secondary? J. Clin. Med. 2021, 10, 5901
por: de Reuver, Steven, et al.
Publicado: (2022)

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
por: Feyaerts, Dorien, et al.
Publicado: (2021)

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
por: Feyaerts, Dorien, et al.
Publicado: (2022)

Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics
por: Song, Fei, et al.
Publicado: (2014)

Omicron severity: milder but not mild
por: Nealon, Joshua, et al.
Publicado: (2022)

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
por: Pain, Clare E, et al.
Publicado: (2020)

Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
por: Epstein, Jay, et al.
Publicado: (2020)

COVID-19 in people with HIV
por: Xu, Zhe, et al.
Publicado: (2020)

The importance of early detection of ENT symptoms in mild-to-moderate COVID-19
por: Spinato, Giacomo, et al.
Publicado: (2021)

GPs should not try to detect mild COPD
por: Enright, Paul, et al.
Publicado: (2020)

Health Perception among Female COVID-19 Patients. Comment on Fernández-de-las-Peñas et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022, 11, 413
por: Ayuso García, Blanca, et al.
Publicado: (2022)

Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
por: Ferreira, Leonardo M. R., et al.
Publicado: (2020)

Liver injury in COVID-19: management and challenges
por: Zhang, Chao, et al.
Publicado: (2020)

Comment on Ivanov et al. Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic. Medicina 2022, 58, 745
por: Ferini, Gianluca
Publicado: (2022)

Strategies for managing patients with psychiatric illness in the reopening period of the COVID-19 pandemic in China
por: Bai, Wei, et al.
Publicado: (2022)

Digital technology and COVID-19
por: Ting, Daniel Shu Wei, et al.
Publicado: (2020)

Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
por: Rijpma, Anne, et al.
Publicado: (2015)

Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
por: Brightling, Christopher E, et al.
Publicado: (2022)

Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia
por: Wood, Nicholas, et al.
Publicado: (2023)

Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19
por: Mu, Xiuying, et al.
Publicado: (2021)

Maintaining HIV care during the COVID-19 pandemic
por: Jiang, Hongbo, et al.
Publicado: (2020)

SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
por: Jiang, He-wei, et al.
Publicado: (2020)

Proteomic blood profiling in mild, severe and critical COVID-19 patients
por: Patel, Hamel, et al.
Publicado: (2021)

Comment on Aasebø, E., et al. “The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles”. Cancers 2020, 12, 1466
por: DeRosa, Peter, et al.
Publicado: (2020)

Azithromycin for mild-to-moderate COVID-19
por: Patel, Jigar, et al.
Publicado: (2021)

Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic
por: Wang, Jigang, et al.
Publicado: (2020)

Cardiac MRI in Patients with Prolonged Cardiorespiratory Symptoms after Mild to Moderate COVID-19
por: Kravchenko, Dmitrij, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a0auc5944gv3s2be4uoobrtsp4